When you absolutely have to recruit patients on time.
Home Company News A Phase III oncology clinical study is starting at Accell Clinical Research.
A Phase III oncology clinical study is starting at Accell Clinical Research.
This Phase III study will be performed at 14 sites across Russian Federation and will recruit 65 patients suffering from primary myelofibrosis, post-polycythemia vera myelofibrosis, or post-essential thrombocythemia myelofibrosis over the period of 12 months.
Company News
our SERVICES MENU
From clinical research associates to hands-on founders, we fiercely pursue our strategic goal: deliver on schedule. We think of ourselves as your development partner, not a vendor.
